|
|
|
 About Us
|
|
| |
|
Our Mission...
To improve the quality of cardiovascular patient care by providing information,
knowledge and tools; implementing quality initiatives; and supporting research that improves patient
care and outcomes.
|
| |
| How does your facility stack up against your peers and competitors?
With our suite of essential benchmarking tools, it's easier than ever to know how
you stand and to become the best you can be. The NCDR™'s flagship registry,
the national CathPCI Registry™, is the gold standard for measuring quality in
the cath lab. It's joined by other benchmarking products which include the ICD Registry™,
CARE Registry™ and the ACTION Registry™. |
| |
| This unparalleled suite of registries empowers you to meet growing
pressure from regulators and payers for outcome-based quality improvement programs.
Enroll now! |
| |
Here's what you'll get from all our registries!
Tools to advance quality improvement in your hospital
- Quarterly comparative institutional outcomes reports with apples to apples comparison and
benchmarking
- Accurate national and peer comparisons
- Standardized data elements and definitions
- Risk-adjusting adverse outcomes
Benefits
- National, secure, confidential and audited. Patient, physician and institutional data remain
confidential. Only anonymous aggregated data are reported for benchmarking purposes. Onsite audits to
confirm data accuracy
- Online dashboards, plus quarterly and annual benchmark reports
- Expert, scientific oversight and clinically experienced support staff
- Available certified software vendors
Training and Orientation
- Training via webinars, user guides, learning labs, and the NCDR™ annual User Group program
- Discounted NCDR™ programs and learning labs
- Monthly Registry Site Manager conference calls with NCDR™ staff
|
ACTION Registry™
The ACTION Registry™ strives to be the largest, most comprehensive national cardiovascular patient
database ever developed in treating patients with acute coronary syndrome (ACS). The ACTION
Registry™ measures outcomes of STEMI and NSTEMI, and combines data collection and quality
reporting features of two leading national ACS registries:
NRMI and
CRUSADE.
The ACTION Registry Steering Committee is lead by Dr. Chris Cannon.
|
CathPCI Registry™
|
ICD Registry™
|
CARE Registry™
The
CARE Registry™ is the first national vascular data registry supporting multiple disciplines of
medicine (cardiology, neurology, radiology and vascular surgery) with the collection, reporting, and
benchmarking of carotid stenting and endarterectomy procedures. The CARE Registry Steering Committee is
lead by Dr. Chris White.
|
|
Each NCDR™ registry is governed by NCDR™'s Management Board and a committee structure that
provide oversight and direction to over 55 employees dedicated to its mission.
|
| |
NCDR Management Board shall provide oversight and direction for NCDR activities, which include:
– Accountability for financial performance;
– Accountability for the quality of Registry products and services;
– Review and approval of Registry policies and strategic and operational plans;
– Advocate, promote and influence key groups regarding the Registry's activities; and
– Set the high level agenda for the NCDR within the ACC community.
The committee shall include a chair, at least two ACC members, one industry representative, and one ACC staff member. Members will serve 3-year terms and will be staggered to maintain consistency.
|
| |
Ralph G. Brindis, M.D., M.P.H., F.A.C.C.
California
|
CHAIR
|
2004 – 2007
|
| |
Steve E. Coy
District of Columbia
|
Member Division Vice President, Education and Quality
|
2004 – 2007
|
| |
Gregory J. Dehmer, M.D., F.A.C.C.
Texas
|
Member
|
2004 – 2007
|
| |
Costas T. Lambrew, M.D., M.A.C.C.
Maine
|
Member Chief Consultant, Quality
|
2004 – 2007
|
| |
Charles R. McKay, M.D., F.A.C.C.
California
|
Member Interventional Task Force
|
2004 – 2007
|
| |
Cary Sennett, M.D., Ph.D.
Pennsylvania
|
Member Industry Representative
|
2004 – 2007
|
| |
Richard E. Shaw, Ph.D., F.A.C.C.
California
|
Member
|
2005 – 2008
|
| |
William S. Weintraub, M.D., F.A.C.C.
Delaware
|
Member
|
2005 – 2008
|
| |
Kathleen M. Hewitt, R.N., M.S.N.
Virginia
|
Staff Liaison-Primary
|
2004 – Present
|
| |
Laura L. Ritzenthaler
District of Columbia
|
Staff Liaison-Secondary
|
2005 – Present
|
|
| |
NCDR ACTION Registry Steering Committee reports to the NCDR Management Board. It provides strategic direction for the ACTION Registry and monitors research and clinical activities to include the following:
– Sets a high level agenda for the strategic direction of the ACTION Registry;
– Advocates, promotes, and influences key groups regarding the ACTION Registry's activities; assures activities conducted by the ACTION Registry Research and Publications Committee and Clinical Support Team are congruent with NCDR methodologies and policies;
– Identifies new opportunities and strategies to further promote utilization of the ACTION registry;
– Establishes working groups as needed to support specific projects.
The committee shall consist of 5 – 7 members and include a chair (appointed with collaborative approval by the partnering societies and the Chair of the NCDR Management Board), at least two ACC members, at least one representative from each partnering organization, if applicable, and an NCDR Chief Medical Officer or an NCDR board member designee.
|
| |
Christopher P. Cannon, M.D., F.A.C.C.
Massachusetts
|
CHAIR
|
2006 – 2009
|
| |
Ralph G. Brindis, M.D., M.P.H., F.A.C.C.
California
|
Member NCDR Chief Medical Officer
|
2006 – 2009
|
| |
Gregg C. Fonarow, M.D., F.A.C.C.
California
|
Member
|
2006 – 2009
|
| |
W. Brian Gibler
|
Member
|
2006 – 2009
|
| |
Costas T. Lambrew, M.D., M.A.C.C.
Maine
|
Member
|
2006 – 2008
|
| |
Erik Magnus Ohman, M.D., F.A.C.C.
North Carolina
|
Member Interventional Task Force
|
2006 – 2008
|
| |
Joseph P. Lynch, RN
Maryland
|
Staff Liaison-Primary
|
2007 – Present
|
|
| |
NCDR Cath PCI Registry Steering Committee shall provide strategic direction for the CathPCI Registry and monitor research and clinical activities to include the following:
– Set a high level agenda for the strategic direction of the Registry.
– Advocate, promote and influence key groups regarding the Registry's activities.
– Assure activities conducted by the Research and Publications Subcommittee and Clinical Support Team are congruent with NCDR methodologies and policy.
– Identify new opportunities and strategies to further promote utilization of the Registry.
– Reports to the NCDR Management Board.
The committee shall consist of 5–7 members and include a chair (appointed with collaborative approval by the partnering societies and the Chair of the NCDR Management Board), at least two ACC members, at least one representative from each partnering organization, and the NCDR Chief Medical Officer or an NCDR Board member designee. Members will serve 3-year term subject to reappointment for a maximum of six consecutive years.
|
| |
William S. Weintraub, M.D., F.A.C.C.
Delaware
|
CHAIR
|
2006 – 2009
|
| |
Gregory J. Dehmer, M.D., F.A.C.C.
Texas
|
Member
|
2006 – 2009
|
| |
David R. Holmes, Jr., M.D., F.A.C.C.
Minnesota
|
Member
|
2006 – 2009
|
| |
Ronald J. Krone, M.D., F.A.C.C.
Missouri
|
Member
|
2006 – 2008
|
| |
David J. Malenka, M.D., F.A.C.C
New Hampshire
|
Member
|
2006 – 2009
|
| |
Mauro Moscucci, M.D., F.A.C.C.
Michigan
|
Member
|
2006 – 2008
|
| |
Erik Magnus Ohman, M.D., F.A.C.C.
North Carolina
|
Member
|
2006 – 2009
|
| |
W. Douglas Weaver, M.D., F.A.C.C.
Micihigan
|
Member
|
2006 – 2008
|
| |
Tony J. Hermann, R.N.
Wisconsin
|
Staff Liaison-Primary
|
2006 – 2009
|
|
| |
NCDR ICD Registry Steering Committee shall provide scientific and clinical support to the development of a National ICD Registry. Their tasks shall include the following:
– Identify and approve a conclusive list of quality indicators that will be reported to participating institutions and possibly CMS.
– Identify data elements and definitions needed to calculate selected quality indicators and enhance the utility of the registry.
– Determine the most appropriate institutional report content and display format.
– Provide guidance in developing content for training manuals given to ICD Registry participants.
– Review and recommend content to be presented at Registry meetings.
– Assist in providing relevant and consistent answers to user questions on data elements.
The steering committee shall include a chair and 6 – 8 members consisting of at least two ACC representatives, two HRS representatives, and one biostatistician specializing in cardiovascular care.
|
| |
Stephen C. Hammill, M.D., F.A.C.C.
Minnesota
|
CHAIR
|
2007 – 2010
|
| |
Ralph G. Brindis, M.D., M.P.H., F.A.C.C.
California
|
Member
|
2007 – 2010
|
| |
Alan H. Kadish, M.D., F.A.C.C.
Illinois
|
Member
|
2007 – 2010
|
| |
Mark S. Kremers, M.D., F.A.C.C.
North Carolina
|
Member
|
2007 – 2010
|
| |
Bruce D. Lindsay, M.D., F.A.C.C.
Missouri
|
Member
|
2007 – 2010
|
| |
Michael J. Mirro, M.D., F.A.C.C.
Indiana
|
Member
|
2007 – 2010
|
| |
Martha J. Radford, M.D., F.A.C.C.
New York
|
Member
|
2007 – 2010
|
| |
Lynne Warner Stevenson, M.D., F.A.C.C.
Massachusetts
|
Member
|
2007 – 2010
|
| |
|
Joel C. Harder, MBA
|
Staff Liaison-HRS
|
2007 – 2010
|
| |
Christine Lang, RN, MSN
|
Staff Liaison-Primary
|
2007 – 2010
|
|
| |
|
NCDR CARE Registry Steering Committee
|
| |
H. Vernon Anderson, M.D., F.A.C.C.
Texas
|
Member
|
2006 – 2009
|
| |
Christopher U. Cates, M.D., F.A.C.C.
Georgia
|
SCAI Representative
|
2006 – 2009
|
| |
Kalon K. L. Ho, M.D., F.A.C.C.
Massachusetts
|
Member
|
2006 – 2009
|
| |
B. Gregory Thompson
Michigan
|
AANS/CNS
|
2008 – 2011
|
| |
Kenneth Rosenfield, M.D., F.A.C.C.
Massachusetts
|
SCAI Representative
|
2006 – 2009
|
| |
Christopher J. White, M.D., F.A.C.C.
Louisiana
|
SCAI Representative
|
2006 – 2009
|
| |
David J. Cohen, MD, MSc
Missouri
|
Member
|
2006 – 2009
|
| |
Walter Koroshetz, MD, FAAN
Massachusetts
|
Member
|
2006 – 2009
|
| |
Michael R. Jaff, DO, FACP, FACC, FAHA (SVMB)
Massachusetts
|
Member
|
2006 – 2009
|
| |
Sari P. Caldwell, MS, CPhT, RCIS
Maryland
|
Staff Liaison-Primary
|
2006 – Present
|
|
|
|